The Inflation Reduction Act (IRA) is expected to influence the clinical development strategies of pharma companies profoundly ...

US biotech Merida Biosciences has launched with $121m in Series A financing to develop therapeutics targeting disease-causing ...

The potential for cell and gene therapies is growing, offering groundbreaking treatments for rare genetic disorders and ...

Degrees has signed a patent licence agreement with Yale School of Medicine for tafenoquine development for babesiosis.

US President Donald Trump has stated that the country is set to announce “major tariffs” on pharmaceutical imports very soon.

Pharma CEOs have told EC President von der Leyen they may shift operations towards the US as trade tensions escalate.

The Montes Claros site in Brazil is just one of many that Novo Nordisk has poured billions of dollars into as part of efforts ...

With liver ailments on the rise, and obesity a key driver, understanding the treatment options available is critical.

The EC has granted marketing authorisation for AbbVie's once-a-day treatment Rinvoq (upadacitinib) 15mg for adults with GCA.

Epsilogen has acquired antibody developer TigaTx in a deal that collates work from the companies’ alternative antibody ...

KalVista has licenced the commercialisation rights for sebetralstat, a hereditary angioedema (HAE) treatment, to Kaken in ...

The CMS has opted not to move forward with a plan that would have extended Medicare coverage to obesity drugs for millions of ...